Advances in oncology have revolutionized cancer treatments, contributing to improved outcomes for many cancer patients. Nevertheless, major challenges remain, especially in rural and remote communities.

Medical communications agencies often generate reports on oncology insights derived from a variety of industry-sponsored activities. Typically, panels of experts gather at invitation-only, closed-door events that facilitate the exchange of knowledge between physicians and other clinical and medical thought leaders. In some cases, Web-based survey platforms extract fresh industry insights from an audience of community […]

Many global companies rely on the success of virtual meetings. While traditional engagement paradigms are heavy on live interactions and building personal relationships, the digital landscape often seems to erase these. However, virtual meetings bring together high-quality professionals regardless of geography and hold promise for highly productive and energetic meetings, all while maintaining the personal quality […]

In a saturated market full of messaging about improved drugs, how do you reach your audience? Of course, it’s all about quality content, but to improve your marketing reach, you also need to use the mechanisms of community to amplify your message. This means understanding the advantages of different messaging mediums and fitting each with highly […]

When cancers are well understood, it’s often because they affect a large-scale, globally diverse population or because they are featured in prominent awareness campaigns that inspire further bumps in research and development activities. However, there are many more types of cancer that fall under the “rare disease” umbrella and require a far savvier approach to […]

Practicing oncologists typically rely on data from clinical trials as a source for making treatment-related decisions. However, new or rare oncology areas are often limited by the clinical trial data available, as agents for some of these indications can be approved on the basis of phase II trials, ie, an inherently smaller patient population. This […]

Oncology is one of the pharma industry’s largest and most appealing sectors, creating a crowded market. In fact, most major pharma companies desire to be seen as leaders in oncology innovation. However, bulging pipelines for the development of oncology drugs find companies competing with similar products and finding new applications for existing targets. The most […]

Advances in technology will have a sizable impact on the oncology sector in the next decade. The trends we will identify in this post include advances in drug development (specifically targeted or combination therapies), use of real-world evidence, and new technologies used in the treatment and guidance of cancer care. Mobile medical apps are a […]

Creative leadership is crucial for helping your company make moves toward innovation in an industry full of challenges, including healthcare reform, changes in technology, and consumer expectations. Aligning your organization’s goals with key stakeholders is more important than ever. In nurturing stakeholder relationships that will help promote and introduce innovative practices, position yourself as creative—this […]